Global zinc deficiency must be corrected by world health organisations Review 09 February 2013 Pages: 4 - 4
Abetimus: encouraging preliminary phase III trial results Media release 09 February 2013 Pages: 6 - 6
Gavilimomab not superior to antithymocyte globulin in steroid-resistant graft-versus-host disease Media release 09 February 2013 Pages: 8 - 8
Meningococcal group C conjugate vaccine effective in UK adolescents Clinical study 09 February 2013 Pages: 8 - 8
Antidepressant maintenance therapy reduces relapse risk Clinical study 09 February 2013 Pages: 10 - 10
Eptifibatide effective in patients with coronary disorders and renal impairment undergoing coronary interventions Clinical study 09 February 2013 Pages: 10 - 10
Adjunctive risperidone therapy improves psychotic symptoms in post-traumatic stress disorder Clinical study 09 February 2013 Pages: 12 - 12
Infliximab: steroid-sparing effect in paediatric Crohn's disease Clinical study 09 February 2013 Pages: 12 - 12
Reboxetine superior to paroxetine for major depressive disorder Clinical study 09 February 2013 Pages: 13 - 13
Baseline CD8+ level predictive of HAART outcome in paediatric patients Clinical study 09 February 2013 Pages: 14 - 14
Combination gemcitabine + cisplatin therapy for recurrent ovarian cancer News item 09 February 2013 Pages: 14 - 14
Risperidone, donepezil coadministration not associated with significant drug interactions Volunteers 09 February 2013 Pages: 15 - 15
Antiretrovirals: no increase in CV or cerebrovascular disease rates Incidence study 09 February 2013 Pages: 16 - 16
High serum digoxin concentration associated with increased mortality Clinical study 09 February 2013 Pages: 16 - 16
AstraZeneca's lipid-lowering product rosuvastatin [`Crestor'] is being launched in Canada News item 09 February 2013 Pages: 17 - 17
Azathioprine and cyclosporin approved in Japan for use in lung transplantation News item 09 February 2013 Pages: 17 - 17
HRT increases risk of heart disease, MI and death in diabetic women Incidence study 09 February 2013 Pages: 17 - 17
Methyl aminolevulinate recommended for approval for actinic keratosis in Australia Media release 09 February 2013 Pages: 17 - 17